• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

ADDING PRODUCTS

Senetek expanded its manufacturing licensing agreement with ICN Pharmaceuticals Inc. for products containing Senetek's skincare ingredient Kinetin.

Related Videos
Related Content
Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients
October 9th 2024

Psychosocial Impact of Alopecia Areata on Pediatric and Adolescent Patients

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Unmasking Botulinum Toxin Myths
September 13th 2024

Unmasking Botulinum Toxin Myths

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors
September 10th 2024

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy
September 9th 2024

Availability of Apremilast in US for Pediatric Patients Opens Avenues for Expanded Treatment Options and Oral Therapy

© 2024 MJH Life Sciences

All rights reserved.